Skin Health Institute recognised at ACD ASM 

Skin Health Institute recognised at ACD ASM 

During the highly anticipated Australasian College of Dermatologists Annual Scientific Meeting (ACD ASM), the outstanding achievements of the dermatology community including several Skin Health Institute (SHI) staff and consultants were recognised. 


SHI Consultant Dr Michelle Goh was appointed as the ACD Chief Examination Officer. Registrar Dr Dale Jobson was acknowledged with the Adrian Johnson Prize, awarded for the best publication by a trainee in the esteemed Australasian Journal of Dermatology, and Dr Seamus McWhirter and Dr Blake Mumford, who were recognised for their outstanding presentations at the conference.  


Congratulations to new ACD President Dr Adriene Lee, who was officially instated at the AGM succeeding Immediate Past President Dr Clare Tait, who has completed her two-year term in the role. 


We would also like to extend our congratulations to Dr Adrian Lim, the newly appointed President-Elect of the ACD. 


Additionally, we would like to acknowledge the dermatology registrars who have become Fellows of the ACD. 


At the concurrent ADNA Conference, our nursing staff also received

well-deserved recognition.

Sue Anderson was honoured with the Excellence in Dermatology Nursing Award, reflecting her exceptional dedication and commitment to providing top-quality care to patients and nurse education.


Additionally, Jane Duncan received the Best Poster Award for her poster titled “Overview of Biologic Drugs Prescribed by Dermatologists to Treat Psoriasis in the Adult Australian Population,” showcasing her valuable contributions to dermatology research.



These achievements not only highlight the excellence of our team but also reinforce our commitment to providing exceptional care and advancing dermatological practices. Congratulations once again to all the deserving award recipients and new Fellows of the ACD. 

Psoriasis, a chronic inflammatory skin condition, affects millions of individuals worldwide, including a significant number of Australians. This August, during Psoriasis Awareness Month, we aim to shed light on this prevalent condition, raise awareness, and emphasise the importance of empathy and support for those living with psoriasis.

In Australia, psoriasis is estimated to impact approximately 2-3% of the population, making it a relatively common dermatological concern. Despite its prevalence, psoriasis remains widely misunderstood, leading to misconceptions and stigmatisation among patients.

At the Skin Health Institute, we have committed our support to Psoriasis Awareness Month with a mission to create empathy and awareness for people with psoriasis and promote a better understanding of this condition. We recognise that beyond medical treatment, patients need compassionate support and understanding from their communities. Through various initiatives, we strive to foster an environment of compassion and knowledge, allowing patients to feel heard and supported as they learn to manage their condition.

Our dedication to enhancing dermatological care extends to providing the latest treatment options. Our Advanced Targeted Therapies Clinic offers cutting-edge therapies that specifically address psoriasis, tailored to each patient’s unique needs. Our expert dermatologists work closely with patients to develop personalised treatment plans, empowering them to manage their condition effectively and improve their quality of life.

Education is key to unlocking progress in dermatology, so through our suite of educational resources, we seek to help health professionals to stay at the forefront of their clinical practice. Our Masterclasses, GP Workshops, Advanced Therapeutics Education Portal, and Spot Diagnosis podcast episodes provide valuable insights and updates on psoriasis management and treatment options.

As part of our commitment to advancing psoriasis research, we are actively conducting clinical trials focused on nail and body psoriasis. These trials play a crucial role in uncovering innovative treatments and improving outcomes for people with psoriasis. By participating in our clinical trials, individuals not only contribute to medical advancements but also have the opportunity to access potential breakthrough therapies.

During Psoriasis Awareness Month and beyond, we stay dedicated in the pursuit of improving patient outcomes, expanding healthcare professional knowledge and advancing treatment options.         

Scroll to Top